Capital One Investing’s iShares Biotechnology ETF IBB Stock Holding History

Capital One Investing’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$699K	Sell	7,017 -815	-10%	-$85.3K	0.16%	99
2019 Q2	$854K	Buy	7,832 +185	+2%	+$19.7K	0.21%	77
2019 Q1	$855K	Buy	7,647 +540	+8%	+$59.2K	0.23%	74
2018 Q4	$685K	Buy	+7,107	New	+$754K	0.24%	68

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Natixis Paris, France $28B AUM 26.79% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Capital One Investing's IBB Position: Q3 2019 in Review

Capital One Investing reduced its iShares Biotechnology ETF (IBB) stake by 10% in Q3 2019, selling an estimated $85.3K and leaving 7,017 shares worth $699K. The position accounts for 0.16% of the portfolio, ranked #99.

Capital One Investing first reported a position in IBB in Q4 2018 and has held it in 4 quarters since. The position peaked at $855K in Q1 2019. 597 funds tracked by Wall St. Rank hold IBB as of Q3 2019.

Capital One Investing held 7,017 shares of iShares Biotechnology ETF worth $699K as of Q3 2019.
Capital One Investing sold 815 iShares Biotechnology ETF shares in Q3 2019, an estimated $85.3K.
iShares Biotechnology ETF made up 0.16% of Capital One Investing's portfolio in Q3 2019, its #99 holding.
Capital One Investing first reported a position in iShares Biotechnology ETF in Q4 2018 and has held it in 4 quarters since.
Capital One Investing's iShares Biotechnology ETF position peaked at $855K in Q1 2019.
597 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2019.

Based on Capital One Investing's 13F filing for Q3 2019, filed 14 Nov 2019.